Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ablavar

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Magnetic resonance imaging (MRI) plays an important role in the imaging of children with non-central nervous system malignancies… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2014
Review
2014
Magnetic Resonance Imaging (MRI) contrast agents most commonly agents used in diagnosing different diseases. Several agents have… Expand
2013
2013
Methods Simulation study: In vitro studies have shown Ablavar to be 80-90% bound to albumin, with up to 10 fold relaxivity… Expand
  • table 1
  • figure 1
Review
2013
Review
2013
While research exploring the utility of intravascular gadolinium based contrast agents (GBCA), such as gadofosveset (Vasovist… Expand
2013
2013
Learning Objectives 1. Identify various clinical conditions which cause pelvic venous dilatation and/or obstruction. 2. Describe… Expand
2012
2012
To investigate enhancement of hepatic lesions with gadofosveset trisodium (Gdfos) (Ablavar) (blood pool agent) compared with the… Expand
2012
2012
This case report is a unique presentation of a new potential indication for Gadofosvest (Ablavar), a blood pool contrast agent… Expand
2012
2012
We evaluated R1 curves, CNR and scar visualization and quantification in a dog model of myocardial infarction by CMR, using three… Expand
  • table 1
  • figure 1
Review
2012
Review
2012
  • Mark Lewis, S. Yanny, Paul N Malcolm
  • Journal of medical imaging and radiation oncology
  • 2012
  • Corpus ID: 25187442
Gadofosveset trisodium (Ablavar®, formerly Vasovist®) is the first intravascular contrast agent approved for clinical use in… Expand
2010
2010
INTRODUCTION. Pulse wave velocity (PWV) is an indirect measure of vascular stiffness that is used as a biomarker of… Expand
  • table 1